Latest news
SKYLIGHT Phase 2 trial launch lifts Spyre Therapeutics stock 1.4% - Traders UnionTraders Union · Mon, 10 Aug 2026 12:25:23 GMTSpyre Therapeutics launches SPY772 and initiates SKYLIGHT Phase 2 trial for hidradenitis suppurativa - Traders UnionTraders Union · Mon, 10 Aug 2026 12:25:08 GMTSpyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:21:27 GMTUpdate: Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 2Q26 - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:21:16 GMTKvika banki hf.: Transaction in relation to a share buy-back programme - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:21:11 GMT